Germline Genetic Testing in Breast Cancer: Utilization and Disparities in a Middle-Income Country

PURPOSELow rates of germline genetic testing (GGT) for breast cancer (BC) have been reported globally, with limited data from low- and middle-income countries (LMICs). In this study, we used real-world data to assess the GGT rate for BC in an LMIC and identified barriers to its use.METHODSWe analyze...

Full description

Saved in:

Bibliographic Details
Main Authors:	Alessandra Borba Anton de Souza, Carlos Barrios, Rafaela Gomes de Jesus, Tomas Reinert, Juliana Giacomazzi, Daniela D. Rosa, Eduardo Cronemberger, Gustavo Werutsky, José Bines, Geraldo Silva Queiroz, Vladmir Cordeiro de Lima, Ruffo Freitas-Junior, José d'Oliveira Couto Filho, Karla Emerenciano, Heloisa Resende, Susanne Crocamo, Brigitte Van Eyll, Yeni Neron, Vanessa Dybal, Nicolas Silva Lazaretti, Rita de Cassia Costamilan, Diocesio Alves Pinto de Andrade, Clarissa Mathias, Giovana Zerwes Vacaro, Giuliano Borges, Alessandra Menezes Morelle, Carlos Alberto Sampaio Filho, Max Mano, Martina Lichtenfels, Sergio D. Simon, Andre P. Fay
Format:	Article
Language:	English
Published:	American Society of Clinical Oncology 2025-04-01
Series:	JCO Global Oncology
Online Access:	https://ascopubs.org/doi/10.1200/GO-24-00337
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Germline Genetic Testing in Breast Cancer: Utilization and Disparities in a Middle-Income Country

Similar Items